V

VKTX

Viking Therapeutics Inc

25.79

0.31+1.22%
After Hours: 25.35  -0.44  -1.71%19:59 04/23 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Cash from Operating Activities

-87.79M

-73.38M

-48.40M

-47.59M

-21.78M

Net Income

-109.96M

-85.89M

-68.87M

-54.99M

-39.49M

Depreciation/Depletion & Amortization

346.00K

292.00K

291.00K

296.00K

277.00K

Deferred Taxes

--

--

--

--

--

Non-Cash Items

12.46M

8.68M

9.99M

10.04M

9.72M

Changes in Working Capital

9.36M

3.55M

10.19M

-2.93M

7.72M

Cash from Investing Activities

-553.37M

-179.09M

54.75M

37.96M

41.57M

Capital Expenditures

--

--

--

--

--

Other Investing Cash Flow Items, Total

-553.37M

-179.09M

54.75M

37.96M

41.57M

Cash from Financing Activities

612.46M

271.38M

4.16M

6.88M

950.00K

Financing Cash Flow Items

601.65M

264.61M

10.11M

-753.00K

-322.00K

Total Cash Dividends Paid

--

--

--

--

--

Issuance (Retirement) of Stock, Net

10.81M

6.77M

-5.95M

7.63M

1.27M

Issuance (Retirement) of Debt, Net

--

--

--

--

--

Foreign Exchange Effects

-148.00K

-30.00K

-258.00K

--

--

Net Change in Cash

-28.84M

18.88M

10.26M

-2.75M

20.74M

Cash Interest Paid

--

--

--

--

--

Cash Taxes Paid

--

--

--

--

--